web3: The scale of Solana tokenized funds has increased by $468 million this year

Citi published a research report maintaining a "Neutral" rating on the e-signature and agreement cloud platform DocuSign, with a target price of $72.

Reuters, October 9 – In pre-market trading on Friday, shares of Humana (stock code: HUM.N) rose by 15%. Analysts said the health insurer is set to be the biggest beneficiary of the new 2027 Medicare Advantage star ratings. Humana stated that, with improvements in healthcare quality and member experience indicators, 95% of its Medicare Advantage members will be enrolled in plans rated four stars or higher by 2027, a substantial jump from 20% in 2026 (link). JPMorgan analysts noted that they had previously projected this ratio to be between 60% and 70%. The U.S. Department of Health and Human Services uses a one- to five-star scale to rate Medicare Advantage and prescription drug plans. Higher ratings lead to government bonuses worth billions of dollars and can help attract more members. Analysts noted that Humana’s ratings performance outpaced its larger competitors: JPMorgan expects the proportion of UnitedHealth Group’s (UNH.N) plans rated four stars or higher to decrease from 81% to about 67%, while CVS Health’s (CVS.N) ratio will fall from 84% to about 70%. The U.S. Department of Health and Human Services said Thursday night that, overall, about 71% (link) of Medicare Advantage prescription drug plan enrollees will be in contracts rated four stars or higher in 2027. Evercore ISI analyst Elizabeth Anderson said that Humana had improved in prescription drug plan quality, health plan quality, and readmission rates. She added, “This improvement reflects management’s increased focus on these metrics over the past year.” Health insurers provide Medicare Advantage plans for the government to adults aged 65 and older and people with disabilities.

Reuters, October 9 – After two consecutive weeks of net inflows, U.S. equity funds saw net outflows for the week ending October 7, as investors took profits during a market rally while concerns persisted over rising Treasury yields and sustained high oil prices. LSEG Lipper data shows investors withdrew a net $5.11 billion from U.S. equity funds during the week, marking the first weekly net outflow since September 16. The S&P 500 index (.SPX) hit a record high of 7,844.52 points earlier in the week before retreating. Mounting inflation concerns fueled a sharp selloff in the bond market, driving the yield on the 10-year Treasury to 5.3645%, its highest level since April 2002, dampening market sentiment. Large-cap, mid-cap, and small-cap U.S. equity funds recorded net redemptions of $14.08 billion, $1.03 billion, and $834 million, respectively. However, investors made net purchases of $5.68 billion in sector funds, led by technology, which attracted $4.53 billion. The utilities and industrials sectors absorbed $1.18 billion and $1.04 billion, respectively. U.S. bond funds posted net inflows of $19.78 billion for the week, a historic high. Investors poured $6.76 billion into short- to intermediate-term government and Treasury funds, the highest in six months. Short- to intermediate-term investment-grade funds and general domestic taxable fixed income funds saw net inflows of $5.04 billion and $2.52 billion, respectively. Meanwhile, money market funds attracted $68.49 billion, reversing the previous week’s $43.6 billion in outflows. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to possible inaccuracies or lack of context in automated translations, Reuters does not guarantee the accuracy of such texts and provides them solely for the convenience of readers. Reuters accepts no liability for any damage or loss caused by the use of automated translation services.)